Is it Time for CD5+ B-cell Malignancies to have a New Taxonomy?Douglas Smith*
Division of Hematologic Malignancies, Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, USA
- *Corresponding Author:
- Douglas Smith
Associate Professor of Oncology
Division of Hematologic Malignancies
Sidney Kimmel Cancer Center at Johns Hopkins
1650 Orleans Street, CRB1 room 246 Baltimore
Maryland 21287, USA
Tel: (410) 614-5068
E-mail: [email protected]
Received date: January 30, 2014; Accepted date: March 20, 2014; Published date: April 07, 2014
Citation: Smith D (2014) Is it Time for CD5+ B-cell Malignancies to have a New Taxonomy? J Leuk (Los Angel) 2:133. doi: 10.4172/2329-6917.1000133
Copyright: © 2014 Smith D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Virtually everything has a name. With names, we hope to succinctly convey a set of qualities allowing for the rapid communication of ideas. In regards to neoplastic diseases of the blood we have re-categorized and re-named illnesses for years.